Literature DB >> 55271

Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.

P R Twentyman, N M Bleehen.   

Abstract

Studies have been carried out into the effect usually referred to as "repair to potentially lethal damage" following the treatment of cells with bleomycin. In vitro, increased survival was seen with delayed subculture of cells in both exponential phase and plateau phase. It was unimportant whether the medium present during the delay period had been previously used to support cell growth. Exposure of cells growing as a solid tumour in vivo to bleomycin (4 mg/kg), gave a surviving fraction of 2 X 10(-3) if assay was carried out at 30 min but a surviving fraction of virtually 100% if assay was delayed until 6 h. Various possible artefacts have been eliminated as reasons for the observations but doubts are raised regarding the nature of the mechanism involved.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 55271      PMCID: PMC2024758          DOI: 10.1038/bjc.1975.251

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Repair of potentially lethal damage in x-irradiated HeLa cells.

Authors:  R A Phillips; L J Tolmach
Journal:  Radiat Res       Date:  1966-11       Impact factor: 2.841

2.  The effect of bleomycin and radiation in combination on bacteria and mammalian cells in culture.

Authors:  N M Bleehen; N E Gillies; P R Twentyman
Journal:  Br J Radiol       Date:  1974-06       Impact factor: 3.039

3.  Radioautographic studies on the intracellular distribution of bleomycin-14C in mouse tumor cells.

Authors:  J Fujimoto
Journal:  Cancer Res       Date:  1974-11       Impact factor: 12.701

4.  Potentiation of bleomycin by an antifungal polyene, pentamycin, in transformed animal cells.

Authors:  T Nakashima; M Kuwano; K Matsui; S Komiyama; I Hiroto
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

5.  Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents.

Authors:  G R Ray; G M Hahn; M A Bagshaw; S Kurkjian
Journal:  Cancer Chemother Rep       Date:  1973 Nov-Dec

6.  Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure.

Authors:  G M Hahn; G R Ray; L F Gordon; R F Kallman
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

7.  Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative.

Authors:  S C Rockwell; R F Kallman; L F Fajardo
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

8.  Potentially lethal radiation damage: repair by mammalian cells in culture.

Authors:  J A Belli; M Shelton
Journal:  Science       Date:  1969-08-01       Impact factor: 47.728

9.  Demonstration of repair of potentially lethal damage in plateau phase cells of Ehrlich ascites tumor after exposure to bleomycin.

Authors:  Y Takabe; T Miyamoto; T Terashima
Journal:  Gan       Date:  1974-12

10.  Plateau-phase cultures of mammalian cells: an in vitro model for human cancer.

Authors:  G M Hahn; J B Little
Journal:  Curr Top Radiat Res Q       Date:  1972-07
View more
  15 in total

1.  CB 1954 revisited. I. Disposition kinetics and metabolism.

Authors:  P Workman; R A White; K Talbot
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Modulation of bleomycin cytotoxicity.

Authors:  C W Moore
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

3.  New type of recovery in HeLa cells exposed to bleomycin.

Authors:  T Miyamoto; M Wakabayashi; T Terasima
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

4.  Synergism of X-rays and bleomycin on Ehrlich ascites tumour cells.

Authors:  Y Takabe; T Miyamoto; M Watanabe; T Terasima
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

5.  Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

Authors:  T C Stephens; J H Peacock
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

6.  Inhibition of the recovery from potentially lethal damage by lonidamine.

Authors:  G M Hahn; I van Kersen; B Silvestrini
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

7.  Preclinical pharmacokinetics of benznidazole.

Authors:  P Workman; R A White; M I Walton; L N Owen; P R Twentyman
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

8.  Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.

Authors:  D J Honess; P Workman; J E Morgan; N M Bleehen
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

9.  Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.

Authors:  P R Twentyman
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

10.  Separation of clonogenic tumour cells from EMT6 mouse mammary tumours.

Authors:  P R Twentyman; J V Watson
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.